Lobbying Filing Details

Total Spending

$70,000

Activities

1

Lobbyists

3

Gov't Entities

0

Filing Information
Filing UUID:
6ea7ea12-56c0-4192-9413-98f99d4a9647
Type:
Q1 - 1st Quarter - Report
Period:
2026 - 1st Quarter (Jan 1 - Mar 31)
Date Posted:
April 06, 2026 at 2:25 PM
Income:
$70,000
Expenses:
$0
Document URL:
View Submission
Quick Info
  • Document Type: text/html
  • Posted By: Rachel Sher
Registrant
MANATT, PHELPS, AND PHILLIPS

Law firm

Washington, District of Columbia
Client
DENALI THERAPEUTICS

Biopharmaceutical Company

California, United States of America
Lobbying Activities (1)
Activity 1
Health Issues

Rare Pediatric Disease Priority Review Voucher (PRV) Program Reauthorization; Rare disease drug development

Lobbyists (3)
  • HEIDE BAJNRAUH
  • MRS. KENDALL BYRUM HUSSEY
  • RACHEL SHER

Source: LDA.gov, data retrieved November 10, 2026. FilingExplorer is not affiliated with LDA.gov; the Senate Office of Public Records cannot vouch for data or analyses derived from these records after retrieval.